Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections.

Cruz, Clênio Silva; Ricci, Mayra Fernanda; Vieira, Angélica Thomaz

Cruz, Clênio Silva; Ricci, Mayra Fernanda; Vieira, Angélica Thomaz.

Afiliación

Cruz CS; Laboratory of Microbiota and Immunomodulation (LMI), Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Ricci MF; Laboratory of Microbiota and Immunomodulation (LMI), Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Vieira AT; Laboratory of Microbiota and Immunomodulation (LMI), Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Front Pharmacol ; 12: 724033, 2021.

Article en En | MEDLINE | ID: mdl-34557097

Palabras clave

gut-lung axis; immunobiotics; inflammation; microbiota; mucosal immmunity; prebiotcs; probiotics; symbiotics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google